Cara L Alfaro - FDA Investigator Report
Designation: CLINICAL ANALYST
Duty Station: Silver Spring MD 20993-0002
Organizations: DHHS FDA CDER OMPT CDER OC OSI DCCE GCPAB
Overview Statistics
4
Total Inspections
0
Total 483s Issued
0
Warning Letters Issued
Inspection Details
Longest Inspection: 5 days
Shortest Inspection: 4 days
Average Length: 4.8 days
Discover the bigger picture. This is just the tip of the iceberg.
Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.
Schedule a DemoCara L Alfaro's Recent Inspections
| Date | Company | City | Country | FEI Number | 483 |
|---|---|---|---|---|---|
| 2025-03-27 | Eli Lilly & Company | Indianapolis | United States | 1819470 | |
| 2019-02-01 | Nektar Therapeutics | San Francisco | United States | 3008943810 | |
| 2017-12-08 | David Kudrow, M.D. | Santa Monica | United States | 3008771907 | |
| 2016-11-18 | Julio C. Castro-Gayol, M.D. | Hialeah | United States | 3012801648 |
Sign Up to get the complete report.
Download 483s and EIRs for Cara L AlfaroCara L Alfaro - Co-Inspectors
| Name | Inspections | Last Inspection |
|---|---|---|
| Joanne M Schlossin | 1 | 2025 |
| Dustin R Abaonza | 1 | 2019 |
| Lakecha N Lewis | 1 | 2017 |
| Craig A Garmendia | 1 | 2016 |
Cara L Alfaro's Active Locations
- United States
Cara L Alfaro's Year-wise Inspection Count
- 2016:1 inspections
- 2017:1 inspections
- 2019:1 inspections
- 2025:1 inspections
Last Updated: 2025-05-14 06:11:22